blue cross blue shield semaglutide coverage Is Wegovy covered by Shield? Blue Cross Blue Shield of

Zealand Pharma's agreement with Roche to jointly develop and commercialise an experimental amylin-based weight-loss treatment will create a strong obesity trea

For a person with type 1 diabetes, it is completely healthy to donate blood

Try our signature GLP-1 Support System featuring SoWell Electrolyes, SoWell Protein, and SoWell Fiber.

Nearly three months after winning a contentious bid to buy obesity drugmaker Metsera Inc

Jardiance plus Januvia can enhance glycemic control safely

As of early 2026, several potent single, dual, and triple incretin receptor agonists are in Phase 2/3 trials for MASH including : Survodutide : A dual glucagon (GCGR)/GLP-1 receptor agonist that has shown significant MASH resolution in Phase 2 trials